|
|
Gene Symbol |
LRP5 |
|
Aliases |
BMND1, EVR1, EVR4, HBM, LR3, LRP-5, LRP-7, LRP7, OPPG, OPS, OPTA1, PCLD4, VBCH2 |
|
Entrez Gene ID |
|
|
Gene Name |
LDL receptor related protein 5 |
|
Chromosomal Location |
11q13.2 |
|
HGNC ID |
|
|
Summary |
This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0001702 |
Biological process |
Gastrulation with mouth forming second |
IBA |
21873635 |
GO:0002053 |
Biological process |
Positive regulation of mesenchymal cell proliferation |
IMP |
17680723 |
GO:0002076 |
Biological process |
Osteoblast development |
IBA |
21873635 |
GO:0006007 |
Biological process |
Glucose catabolic process |
IMP |
19673927 |
GO:0008217 |
Biological process |
Regulation of blood pressure |
IMP |
18721193 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IDA |
9790987 |
GO:0009952 |
Biological process |
Anterior/posterior pattern specification |
IBA |
21873635 |
GO:0042632 |
Biological process |
Cholesterol homeostasis |
IBA |
21873635 |
GO:0042632 |
Biological process |
Cholesterol homeostasis |
IMP |
18721193, 20146170 |
GO:0045600 |
Biological process |
Positive regulation of fat cell differentiation |
IMP |
17680723 |
GO:0045668 |
Biological process |
Negative regulation of osteoblast differentiation |
IMP |
17680723 |
GO:0045840 |
Biological process |
Positive regulation of mitotic nuclear division |
IDA |
9790987 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IDA |
15035989, 17955262 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
12857724 |
GO:0046849 |
Biological process |
Bone remodeling |
IBA |
21873635 |
GO:0048539 |
Biological process |
Bone marrow development |
IBA |
21873635 |
GO:0048539 |
Biological process |
Bone marrow development |
IMP |
17680723 |
GO:0060042 |
Biological process |
Retina morphogenesis in camera-type eye |
IMP |
15346351 |
GO:0060070 |
Biological process |
Canonical Wnt signaling pathway |
IBA |
21873635 |
GO:0060070 |
Biological process |
Canonical Wnt signaling pathway |
IDA |
11029007, 12121999, 12857724, 15908424, 24706814, 25920554 |
GO:0060070 |
Biological process |
Canonical Wnt signaling pathway |
IGI |
11336703, 16805831 |
GO:0060070 |
Biological process |
Canonical Wnt signaling pathway |
IMP |
18044981, 19673927 |
GO:0060349 |
Biological process |
Bone morphogenesis |
IBA |
21873635 |
GO:0060349 |
Biological process |
Bone morphogenesis |
IMP |
19673927, 20146170, 20630166 |
GO:0060444 |
Biological process |
Branching involved in mammary gland duct morphogenesis |
IBA |
21873635 |
GO:0060612 |
Biological process |
Adipose tissue development |
IBA |
21873635 |
GO:0060612 |
Biological process |
Adipose tissue development |
IMP |
17680723 |
GO:0061178 |
Biological process |
Regulation of insulin secretion involved in cellular response to glucose stimulus |
IBA |
21873635 |
GO:0061304 |
Biological process |
Retinal blood vessel morphogenesis |
IBA |
21873635 |
GO:0061304 |
Biological process |
Retinal blood vessel morphogenesis |
IMP |
15024691, 15346351 |
GO:0071901 |
Biological process |
Negative regulation of protein serine/threonine kinase activity |
IMP |
19107203 |
GO:0005886 |
Cellular component |
Plasma membrane |
IBA |
21873635 |
GO:0005886 |
Cellular component |
Plasma membrane |
IDA |
17680723 |
GO:0043235 |
Cellular component |
Receptor complex |
IBA |
21873635 |
GO:0043235 |
Cellular component |
Receptor complex |
IDA |
18762581 |
GO:1990851 |
Cellular component |
Wnt-Frizzled-LRP5/6 complex |
TAS |
20093360, 22988876 |
GO:1990909 |
Cellular component |
Wnt signalosome |
NAS |
24115276 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
11336703, 11433302, 15908424, 18762581, 20393562, 21471202 |
GO:0017147 |
Molecular function |
Wnt-protein binding |
IBA |
21873635 |
GO:0017147 |
Molecular function |
Wnt-protein binding |
IPI |
11336703 |
GO:0017147 |
Molecular function |
Wnt-protein binding |
TAS |
22988876 |
GO:0019534 |
Molecular function |
Toxin transmembrane transporter activity |
IMP |
18350154 |
GO:0042813 |
Molecular function |
Wnt-activated receptor activity |
IBA |
21873635 |
GO:0042813 |
Molecular function |
Wnt-activated receptor activity |
IDA |
24706814, 25920554 |
GO:0071936 |
Molecular function |
Coreceptor activity involved in Wnt signaling pathway |
IPI |
11336703 |
GO:1904928 |
Molecular function |
Coreceptor activity involved in canonical Wnt signaling pathway |
NAS |
24431302 |
|
Protein Information |
|
Protein Name |
Low-density lipoprotein receptor-related protein 5, low density lipoprotein receptor-related protein 5, low density lipoprotein receptor-related protein 7 |
|
Function |
Acts as a coreceptor with members of the frizzled family of seven-transmembrane spanning receptors to transduce signal by Wnt proteins (PubMed:11336703, PubMed:11448771, PubMed:15778503, PubMed:11719191, PubMed:15908424, PubMed:16252235). Activates the canonical Wnt signaling pathway that controls cell fate determination and self-renewal during embryonic development and adult tissue regeneration (PubMed:11336703, PubMed:11719191). In particular, may play an important role in the development of the posterior patterning of the epiblast during gastrulation (By similarity). During bone development, regulates osteoblast proliferation and differentiation thus determining bone mass (PubMed:11719191). Mechanistically, the formation of the signaling complex between Wnt ligand, frizzled receptor and LRP5 coreceptor promotes the recruitment of AXIN1 to LRP5, stabilizing beta-catenin/CTNNB1 and activating TCF/LEF-mediated transcriptional programs (PubMed:11336703, PubMed:25920554, PubMed:24706814, PubMed:14731402). Acts as a coreceptor for non-Wnt proteins, such as norrin/NDP. Binding of norrin/NDP to frizzled 4/FZD4-LRP5 receptor complex triggers beta-catenin/CTNNB1-dependent signaling known to be required for retinal vascular development (PubMed:27228167, PubMed:16252235). Plays a role in controlling postnatal vascular regression in retina via macrophage-induced endothelial cell apoptosis (By similarity). |
|
|
|
|
|
UniProt |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000236826 |
|
|
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Genetic Diseases |
|
Van Buchem disease |
|
Retinopathy of Prematurity |
|
Worth disease |
|
Endocrine System Diseases |
PCOS |
|
Eye Diseases |
Vitreoretinopathy |
15981244, 20340138, 16929062, 24715757, 15024691, 15346351, 16252235, 19324841, 28041643, 25711638, 18263894, 27228167 |
Musculoskeletal Diseases |
Osteoporosis with pseudoglioma |
|
Osteoporosis |
|
|
References |
|
|
Aydos Alp, Gurel Aykut, Oztemur Islakoglu Yasemin, Noyan Senem, Gokce Bagdagul, Ecemis Tolga, Kaya Cemil, Aksu Arif Tarik, Gur Dedeoglu Bala |
Biotechnology Institute, Ankara University, Ankara, Turkey.| Test Tube Babies Unit, HRS Women Hospital, Ankara, Turkey.| Biotechnology Institute, Ankara University, Ankara, Turkey.| Biotechnology Institute, Ankara University, Ankara, Turkey.| Test Tube Babies Unit, Medicana International Ankara Hospital, Ankara, Turkey.| Department of Gynecology and Obstetrics, Liv Hospital, Ankara, Turkey.| Department of Gynecology and Obstetrics, TOBB ETU Hospital, Ankara, Turkey.| Department of Gynecology and Obstetrics, HRS Women Hospital, Ankara, Turkey.| Biotechnology Institute, Ankara University, Ankara, Turkey. |
PLoS One. 2016 Dec 20;11(12):e0168875. doi: 10.1371/journal.pone.0168875. |
Abstract
Polycystic ovary syndrome (PCOS) is a metabolic and endocrine disorder which affects women of reproductive age with prevalence of 8-18%. The oocyte within the follicle is surrounded by cumulus cells (CCs), which connect with mural granulosa cells (MGCs) that are responsible for secreting steroid hormones. The main aim of this study is comparing gene expression profiles of MGCs and CCs in PCOS and control samples to identify PCOS-specific differentially expressed genes (DEGs). In this study, two microarray databases were searched for mRNA expression microarray studies performed with CCs and MGCs obtained from PCOS patients and control samples. Three independent studies were selected to be integrated with naive meta-analysis since raw meta-data from these studies were found to be highly correlated. DEGs in these somatic cells were identified for PCOS and control groups. This study enabled us to reveal dysregulation in MAPK (mitogen activated protein kinase), insulin and Wnt signaling pathways between CCs and MGCs in PCOS. The meta-analysis results together with qRT-PCR validations provide evidence that molecular signaling is dysregulated through MGCs and CCs in PCOS, which is important for follicle and oocyte maturation and may contribute to the pathogenesis of the syndrome. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|